News & Updates

Use of antithrombotic agents at admission does not increase the risk of in-hospital mortality in patients with acute upper gastrointestinal bleeding (UGIB), according to a study, noting a protective trend overall and significant protection in antiplatelet users and nonvariceal bleeding.

A recent study has found no evidence of the noninferiority of low-dose aspirin (LDA) continuation over discontinuation during gastric endoscopic submucosal dissection (ESD) in patients with gastric mucosal neoplasms and low thrombotic risk.

Treatment with antibiotics appears to increase the risk of irritable bowel syndrome (IBS) development, particularly following a gastrointestinal (GI) infection, suggests a study.

Treatment with risankizumab results in fast and sustained favourable clinical, endoscopic, and radiologic outcomes in patients with Crohn’s disease (CD), a real-world study has shown.

More than one in five colorectal cancer (CRC) cases globally could be related to exposure to Helicobacter pylori, with China having the largest absolute number of CRC cases potentially linked to the bacterium, an international collaborative study led by investigators from the University of Hong Kong (HKU) has found.

In the real-world treatment of patients with inflammatory bowel disease (IBD), the use of guselkumab yields high remission rates and has an overall safety profile that mirrors those in randomized controlled trials, according to a large prospective study.

Three proton pump inhibitors (PPIs) demonstrate cardiovascular safety in patients with acute myocardial infarction (MI) receiving dual antiplatelet therapy (DAPT), according to a study. Moreover, use of lansoprazole contributes to a reduced risk of gastrointestinal bleeding.

In the treatment or non-cirrhotic patients with chronic hepatitis C virus (HCV) infection, an 8-week course of sofosbuvir–velpatasvir combination has similar efficacy to the standard 12-week course, according to the open-label RESOLVE trial.

In patients with suspected small bowel bleeding (SSBB), having a haemoglobin level of <8.0 g/dL appears to increase the risk of mortality, suggests a study.

Use of proton pump inhibitors (PPIs) results in improvements in nighttime heartburn and reflux-related sleep disturbances, particularly in patients with reflux-driven nocturnal symptoms, a study has shown.